Impact of sodium phenylbutyrate treatment in acute management of maple syrup urine disease attacks: a single-center experience


ZÜBARİOĞLU T., Dede E., Cigdem H., KIYKIM E., CANSEVER M. Ş., Aktuglu-Zeybek C.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, vol.34, no.1, pp.121-126, 2021 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Volume: 34 Issue: 1
  • Publication Date: 2021
  • Doi Number: 10.1515/jpem-2020-0356
  • Journal Name: JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, EMBASE, MEDLINE
  • Page Numbers: pp.121-126
  • Istanbul University Affiliated: Yes

Abstract

Objectives: Accurate management of metabolic decompensation in maple syrup urine disease (MSUD) has a crucial role, as acute attacks can cause neurological sequels and can be life threatening. Here, we aimed to evaluate effect of sodium phenylbutyrate (NaPBA) in acute management of MSUD attacks.